Impact of musculoskeletal disease on quality of life in long-standing acromegaly

被引:68
作者
Miller, Anne [1 ]
Doll, Helen [2 ]
David, Joel [1 ]
Wass, John [3 ]
机构
[1] Nuffield Orthopaed Ctr, Dept Rheumatol, Oxford OX3 7LD, England
[2] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England
[3] Churchill Hosp, OCDEM, Dept Endocrinol, Oxford OX3 7LJ, England
关键词
D O I
10.1530/EJE-07-0838
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To provide rheumatological assessment of patients with long-standing acromegaly and investigate the impact of musculoskeletal disease on quality of life. Desigin: Cross-sectional observational study. Methods: Fifty-eight patients diagnosed with acromegaly at least 5 years previously were interviewed and examined by a rheumatologist. Each patient completed the short form-36 (SF-36), arthritis impact measurement scales 2 (AIMS2) and acromegaly quality of life questionnaires (AcroQol). Results: Fifty-two out of 58 (90%) reported musculoskeletal pain, with 29 (50%) reporting neck pain. Hip osteoarthritis was present in 49 (84%) and knee osteoarthritis in 20 (34%). Half the patients (52%) reported sleep disturbance, but only 2 (3.5%) had fibromyalgia. Ten (17.2%) had previously,undergone carpal tunnel decompression. Fifty-one (88%)) patients had consulted their general practioner and 31 (54%) complementary therapists. SF-36. AIMS2 and AcroQol scores were lower in patients with musculoskeletal pain. Conclusions: This study of musculoskeletal problems in patients with acromegaly reports systematic rheumatological examination, use of medical services and quality of life scores. Musculoskeletal problems should be routinely addressed in acromegaly by both endocrinologist and rheumatologist and a multidisciplinary approach taken to management.
引用
收藏
页码:587 / 593
页数:7
相关论文
共 25 条
[1]   SLEEP IN ACROMEGALY BEFORE AND AFTER TREATMENT WITH ADENOMECTOMY [J].
ASTROM, C ;
CHRISTENSEN, L ;
GJERRIS, F ;
TROJABORG, W .
NEUROENDOCRINOLOGY, 1991, 53 (04) :328-331
[2]  
BARKAN A, 1977, J ENDOCRINOL, V155, pS41
[3]   Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life [J].
Biermasz, NR ;
Pereira, AM ;
Smit, JWA ;
Romijn, JA ;
Roelfsema, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2731-2739
[4]   Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age [J].
Colao, A ;
Spiezia, S ;
Di Somma, C ;
Pivonello, R ;
Marzullo, P ;
Rota, F ;
Musella, T ;
Auriemma, RS ;
De Martino, MC ;
Lombardi, G .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (05) :440-448
[5]   Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly [J].
Colao, A ;
Cannavò, S ;
Marzullo, P ;
Pivonello, R ;
Squadrito, S ;
Vallone, G ;
Almoto, B ;
Bichisao, E ;
Trimarchi, F ;
Lombardi, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (01) :31-38
[6]  
DETENBECK LC, 1973, CLIN ORTHOP RELAT R, P119
[7]   THE GALS LOCOMOTOR SCREEN [J].
DOHERTY, M ;
DACRE, J ;
DIEPPE, P ;
SNAITH, M .
ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (10) :1165-1169
[8]   ARTHROPATHY IN ACROMEGALIC PATIENTS BEFORE AND AFTER TREATMENT - A LONG-TERM FOLLOW-UP-STUDY [J].
DONS, RF ;
ROSSELET, P ;
PASTAKIA, B ;
DOPPMAN, J ;
GORDEN, P .
CLINICAL ENDOCRINOLOGY, 1988, 28 (05) :515-524
[9]   Pain and sleep disturbances with special reference to fibromyalgia and rheumatoid arthritis [J].
Drewes, AM .
RHEUMATOLOGY, 1999, 38 (11) :1035-1038
[10]   Slow-release lanreotide and octreotide LAR in the medical therapy of acromegaly [J].
Giusti, M ;
Sessarego, P ;
Timossi, G ;
Bocca, L .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142 (06) :697-698